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ABSTRACT: Bioassay guided fractionation of the methanolic extract of Detarium microcarpum Guill using  VLC and 
activity against hepatitis C virus  in the Huh-7 Replicon assay was done. The active fraction MTH-1700 which demonstrated 
good inhibitory and selective potency (83.87%) against Hepatitis C Virus and comparable with 86.76% of the control; RS-
446(2-Me-C) at a concentration of 10 µM was further fractionated by HPLC.  
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INTRODUCTION1 
 
Hepatitis C Virus (HCV) provides the greatest risk of 
all the  chronic liver diseases and it is  the most serious 
hepatitis virus that leads to progressive, life-threatening 
chronic hepatitis, cirrhosis, liver cancer, and liver 
failure (Leikin & Lipsky, 2003). Hepatitis C Virus 
establishes a chronic infection in 50 - 80% of all 
reported cases (Wilber ,1995) and about 90% of the  
sufferers retain the indefinite evidence of it and 
therefore become  carriers of the virus (Leikin & 
Lipsky, 2003). Alpha interferon (IFN-), either alone or 
in combination with ribavirin, is the only approved 
therapy for chronic hepatitis C. Anemia is the most 
common adverse effect associated with ribavirin 
treatment and neuropsychiatric adverse effects of IFN- 
lead to premature cessation of therapy in 10 - 20% of 
the patients (Collier & Chapman, 2001; Di Bisceglie et 
al. 2002). Therefore, the ongoing search for more 
potent antiviral compounds with fewer  adverse effects 
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should be intensified, especially among medicinal 
plants. 
 Detarium microcarpium Guill. (Fabacea) is an 
African leguminous medicinal plant found in the forests 
(Mabberley, 1987) and reported to possess 
antimicrobial and cytotoxic properties (Abreu et al. 
1998; Abreu et al. 1999). The fruits and leaves are used 
traditionally in the treatment of dysentery and syphilis. 
(Iwu, 1993; Ikhiri & Ilagouma 1995) and the root water 
extract is used for leprosy (Collier, 2001). Detarium 
sengalense showed cytotoxicity at 400µg /100 ml and 
antiviral activity against canine parvovirus, poliovirus, 
astrovirus and herpes simplex viruses  (Kudi and 
Myint, 1999). 
 We here report the anti-viral activity of the 
fractions of D. microcarpium using Huh-7 Replicon 
assay. 
 
METHODOLOGY 
 
All chemicals were of analytical grade. Millipore water 
was colleted from a Millipore Millipack® Express, 0.22 
μm water purifier (Millipore; Billerica, MA, USA). 
Vacuum liquid chromatography (VLC) was performed 
on Si gel (70-230 mesh-Merck). VLC on Si gel was 
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carried out with gradient elution using hexane, EtOAc, 
MeOH and water in the order of increasing polarity. 
Preparative HPLC was performed with a waters Prep 
LC system.  
 
 
 
Plant material 
Stem bark of Deterium  microcarpium was collected 
from Ibadan, Oyo State, Nigeria. Voucher specimen 
was deposited in the Forestry Research Institute of 
Nigeria, Ibadan.   
 
Extraction and isolation 
Plant extraction was carried out with MeOH (yield: 
7.4%). Bioassay guided fractionation of the methanolic 
extract (30.0g) was done by VLC using normal phase 
conditions to give ten eleven fractions. The active anti-
viral fraction (MTH-1700 , weight: 6.155g) was further 
fractionated by HPLC (Luna C8 column 21.2 x 250 
mm) using acetonitrile and water as eluents with flow 
rate 15ml/min. Fifteen fractions were collected and 
submitted for bioassay. 
 
Antiviral assay 
The anti-HCV activity was determined in the Huh-7 
clone B cells containing HCV Replicon RNA system. 
Cells were seeded in 96-well tissue culture plates (3 
000 cells/well); the compounds were tested in dose 
response at concentration 10μM (triplicate). After 
addition of test compounds the plates were incubated 
for 5 days (370C, 5%, CO2), total cellular RNA was 
isolated using the Manual Perfect Pure 96 CellVac kit 
from 5 Prime. The replicon RNA and the internal 
control (TaqMan rRNA control reagent, Applied 
Biosystems) were amplified were amplified in a single 
step multiplex Real Time RT-PCR Assay. The antiviral 
potency of the tested metabolites was calculated by 
subtracting the threshold RT-PCR cycle of the test 
compounds from the threshold RT-PCR cycle of the 
negative control (ΔCtHCV). The cytotoxicity of the 
compounds was also calculated by using the ΔCt rRNA 
values. RS-446(2-Me-C) was used as the control. 
. 
RESULTS AND DISCUSSION 
 
Table 1 shows the observed anti-viral activity and 
cytotoxicity of D. microcarpium column fractions in 
the Huh-7 Replicon assay. The active fraction MTH-
1700 (6.155g) which was eluted with EtOAc-MeOH 
(75:25) demonstrated good inhibotry and selective 
potency (83.87%) against Hepatitis C Virus in a dose 
dependent manner compared with control (86.76%) at a 
concentration of 10 µM. Fraction MTH-1698(171mg) 
that was eluted with EtOAc gave higher inhibition 
(94.41%) of the virus but because of the demonstrated 
high toxicity it is regarded as being not selective. 
Hence, D. microcarpium exhibited similar antiviral 
property as Detarium sengalense (Kudi and Myint, 
1999). 
 
Table 1:  
In Vitro activity of D. microcarpium metabolites against HCV in Human clone B cells with host cytotoxicity 
Test agents  ΔCt  HCV 
ΔCt  
rRNA % Inhibition 
   HCV rRNA 
RS-446 2.93 -0.02 86.76 -1.27 
MTH-1695 -0.64 0.07 -55.98 4.83 
MTH-1696 0.48 1.16 28.23 54.98 
MTH-1697 0.68 1.11 37.64 53.61 
MTH-1698 4.17 3.44 94.41 90.68 
MTH-1699 0.24 -0.04 15.28 -2.68 
MTH-1700 2.64 0.34 83.87 21.03 
MTH-1701 -0.11 0.24 -8.15 15.18 
MTH-1702 0.22 0.04 14.10 2.39 
MTH-1703 -0.46 -0.18 -37.42 -13.37 
MTH-1704 -0.75 -0.24 -67.91 -17.90 
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                     Test compounds = 10 µg/ml    RS-446 (2-Me-C) was used as the control = 10 µM 
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